Wadia Saad Alruqayb

Dr. Wadia Saad Alruqayb

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2021 in Drug Safety
Verified
Journal Article
Closed access
PDF file
Wadia Saad AlruqaybWadia Saad Alruqayb
Wadia Saad Alruqayb
MPMalcolm J. Price
Malcolm J. Price
VPVibhu Paudyal
Vibhu Paudyal
ACAnthony R. Cox
Anthony R. Cox

10 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Wadia Saad AlruqaybWadia Saad Alruqayb
Wadia Saad Alruqayb
FBFahad Baali
Fahad Baali
MAManar Althbiany
Manar Althbiany
AAAlanoud Alharthi
Alanoud Alharthi
SASara Alnefaie
Sara Alnefaie
AAAbdullah Ali Alshehri
Abdullah Ali Alshehri
Background: Antibiotic resistance (AMR) is a critical global and national health challenge, largely driven by the misuse and overuse of antibiotics. Understanding the public′s knowledge and practices regarding antibiotic use is essential for informing effective interventions. This study aimed to assess the levels of knowledge, attitude, and practice (KAP) related to antibiotic use among adults in Saudi Arabia’s Western Region and to identify the demographic and behavioral determinants of these outcomes. Methods: A regional cross-sectional survey was conducted from March to June 2025 using a 40-item self-administered online questionnaire. Adults aged ≥ 18 years residing in the Western Region of Saudi Arabia were recruited via social media using snowball sampling. Descriptive statistics and Chi-square tests were used to examine associations, while multivariate logistic regression was employed to identify determinants of high knowledge and good practices, presented as adjusted odds ratios (aOR) with 95% confidence intervals (CI). Results: A total of 891 participants were included; most were female (63.6%) and aged 18–30 years (56.2%). Moderate knowledge of antibiotic use was observed in 54.0% of participants, while 30.8% had high knowledge. In terms of attitude and practice, 55.6% demonstrated good performance and 42.8% average performance. High knowledge was significantly associated with the female gender (aOR = 1.90; 95% CI: 1.34–2.70), age of 41–50 years (aOR = 2.22; 95% CI: 1.42–3.48), and a postgraduate education (aOR = 15.37; 95% CI: 1.84–128.13). Good practices were associated with the female gender (aOR = 2.32; 95% CI: 1.66–3.24) and being married (aOR = 1.99; 95% CI: 1.43–2.77). A moderate positive correlation was found between knowledge and practice scores (r = 0.406, p < 0.001). Conclusions: Significant variability in public KAP regarding antibiotic use was identified. Female gender, older age, and higher education were key determinants of better KAP. These findings emphasize the need for targeted educational strategies focusing on high-risk groups to support rational antibiotic use and mitigate antimicrobial resistance.

18 February 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
MAMohammed S Alharthi
Mohammed S Alharthi
AAAbdullah A. Alshehri
Abdullah A. Alshehri
FBFahad H. Baali
Fahad H. Baali
NANawaf Awd Altuwairqi
Nawaf Awd Altuwairqi
MAMeshari Hassan Altalhi
Meshari Hassan Altalhi
Wadia Saad AlruqaybWadia Saad Alruqayb
Wadia Saad Alruqayb
Background: Seasonal influenza vaccination is essential for reducing the risk and impact of influenza. Makkah region in Saudi Arabia, a destination for millions of pilgrims during Hajj and Umrah, presents a unique context for this study. Therefore, this research investigates the prevalence and influencing factors of influenza vaccine uptake among the public in Makkah region, Saudi Arabia.Method: This cross-sectional study was conducted in Saudi Arabia between February and June 2024. The main researcher developed the questionnaire, which was reviewed by five academics and then piloted with 20 individuals for validation. An online questionnaire was used, targeting residents aged 18 and over with internet access. A snowball sampling method was applied. Data were collected via Google Forms and analyzed using SPSS version 26, employing descriptive statistics such as frequencies, percentages, and means.Results: The total number of respondents is 450 participants, with a response rate of 4.5%. Most respondents were male (71.1%) and aged between 18 and 30 years (44.5%). Education levels varied, with 57.5% holding a bachelor’s degree. Vaccination uptake showed 65.1% had received the vaccine, with 31.1% confident it is safe. Despite this, 58.8% did not get vaccinated this season. Confidence in the vaccine’s effectiveness was 59.5%, though 41.2% reported breakthrough infections. Accessibility was generally rated easy (57.7%). Social pressure (17.4%), trust in health institutions (36.9%), and COVID-19 concerns (36.7%) significantly influenced vaccination decisions. The likelihood of vaccination next season displayed polarized views.Conclusion: This study provides significant insights about vaccine hesitancy that may inform future research endeavors and practical applications. Understanding the various factors that impact the adoption of influenza vaccines offers valuable insights for developing targeted interventions and public health policies to improve vaccination rates. This study enhances theoretical understanding and practical strategies to encourage influenza vaccination, thereby improving public health initiatives in the area and beyond.

4 June 2025 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
MAMajed A. Algarni
Majed A. Algarni
MAMohammed S Alharthi
Mohammed S Alharthi
FBFahad Baali
Fahad Baali
AAAbdulaziz Ibrahim Alzarea
Abdulaziz Ibrahim Alzarea
AAADNAN ALHARBI
ADNAN ALHARBI
MAMohamed H. Abdelazim
Mohamed H. Abdelazim
Background: Olfactory dysfunction is a frequent symptom experienced by individuals recovering from coronavirus disease 2019 (COVID-19) and significantly impacts daily life activities. Recent studies suggest that reducing nasal calcium levels may help restore olfactory function. Glutamate diacetate (GLD) is a natural sequestering agent that binds calcium ions and may offer therapeutic benefits in managing post-COVID olfactory dysfunction. Objective: This study aimed to evaluate the effectiveness of topical GLD treatment in reducing nasal calcium levels and improving olfactory function in individuals with chronic olfactory dysfunction following COVID-19. Methods: A double-blind, placebo-controlled trial was conducted with 66 participants who were randomized into two groups: GLD (1% solution) and saline placebo (0.9% solution). Participants received nasal treatment three times daily for six months. Olfactory function was assessed using the Sniffin’ Sticks test, measuring threshold (T), discrimination (D), and identification (I) scores. Nasal calcium levels were also measured. Statistical analysis included independent t -tests and change-from-baseline comparisons. Results: Significant improvements were observed in the GLD group across olfactory assessments. By month 6, threshold scores increased by 0.78 ± 0.15, discrimination scores by 0.72 ± 0.15, and identification scores by 1.80 ± 0.15, all exceeding gains in the saline group. Nasal calcium levels decreased significantly in the GLD group (7.36 ± 1.21 mM vs 2.49 ± 0.51 mM in saline), suggesting a contribution mechanism in olfactory improvement. Conclusion: GLD treatment resulted in statistically significant improvements in olfactory function and a reduction in nasal calcium levels in individuals with post-COVID olfactory dysfunction. However, the observed changes did not reach the threshold for clinical significance. These findings suggest a potential role for GLD in olfactory recovery, but further studies are needed to evaluate its long-term efficacy and clinical relevance.

4 December 2024 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
Wadia Saad AlruqaybWadia Saad Alruqayb
Wadia Saad Alruqayb
VPVibhu PAUDYAL
Vibhu PAUDYAL
MPMalcolm Price
Malcolm Price
ASAsif Sarwar
Asif Sarwar
JAJeff Aston
Jeff Aston
ACAnthony R. Cox
Anthony R. Cox
Chronic kidney disease (CKD) is associated with comorbidities and altered pharmacokinetics, making appropriate prescribing, and monitoring necessary to minimise drug-related problems (DRPs). Therefore, this study aimed to describe the drug-utilisation pattern in hospitalised CKD patients. An observational study was conducted in hospitalised adult (≥18 years old) CKD patients in the UK using WHO prescribing indicators, from November 2021 to April 2022 in a large teaching hospital in England from admission until discharge. This study used STATA version 16 for analysis. The mean number of drugs per prescription was 11.1(±5), the percentage of encounters resulting in the prescription of an antibiotic was 62%, the percentage of drugs prescribed by generic name was 90%, the percentage of encounters resulting in the prescription of an injection was 94%, and the percentage of drugs prescribed from essential drugs list or formulary was 89%. The most frequent drug group prescribed Alimentary Tract and Metabolism was 22%. Longer hospital stays, admission to a renal ward, and the number of comorbidities were independently associated with polypharmacy. Not all prescribing indicators evaluated in this study were in full compliance with WHO recommendations. Polypharmacy was found in most participants which might require interventions to avoid DRPs. Further research is needed to evaluate factors associated with prescribing in the CKD population and prescriber perspectives on decision-making in the context of available guidelines and patient factors.

20 May 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
FAFahad T. Alsulami
Fahad T. Alsulami
YAYousef Saeed Alqarni
Yousef Saeed Alqarni
Wadia Saad AlruqaybWadia Saad Alruqayb
Wadia Saad Alruqayb
MAMohammed S. Alharthi
Mohammed S. Alharthi
MAMohammad S. Alzahrani
Mohammad S. Alzahrani
MAMubarak S. Alharthi
Mubarak S. Alharthi
Introduction: Adverse drug reaction (ADR) reporting is critical for ensuring medication safety. However, underreporting remains a global concern, particularly in community pharmacy settings. This study explores the behavioral factors influencing community pharmacists’ intention to report ADRs in Saudi Arabia, using the Theory of Planned Behavior (TPB) as a guiding framework.Aims and Objectives: This study aimed to estimate factors affecting community pharmacists’ intention to report ADRs to the Saudi National Pharmacovigilance Center (NPC) through a TPB-based analysis.Methods: A cross-sectional survey was conducted to collect data on pharmacists’ intentions, attitudes, subjective norms, perceived behavioral control, and moral obligation regarding ADR reporting. Descriptive statistics summarized the sample characteristics. Binary logistic regression was used to evaluate the influence of TPB constructs on reporting intentions.Results: Among 452 participating community pharmacists, 88% were aware of the NPC, but only 27.4% had reported ADRs in the past year. Pharmacists who were non-Saudi, aware of the NPC and its procedures, and trained in ADR reporting demonstrated significantly higher intentions to report (p < 0.05). Attitudes (OR = 1.141, 95% CI: 1.09–1.18, p < 0.001), subjective norms (OR = 1.280, 95% CI: 1.16–1.40, p < 0.001), perceived behavioral control (OR = 1.168, 95% CI: 1.03–1.31, p = 0.010), and moral obligation (OR = 1.417, 95% CI: 1.05–1.89, p = 0.019) were all significantly associated with reporting intention.Conclusion: Findings reinforce the importance of targeting TPB constructs (particularly attitudes, social norms, and perceived control) and perceived moral obligation in designing interventions to improve ADR reporting. Strategies such as structured training, institutional support, and promoting moral responsibility may bridge the gap between awareness and actual reporting practices among community pharmacists in Saudi Arabia.